3128.0: Monday, November 13, 2000 - 3:30 PM

Abstract #9385

Development process and cost of an expert system to enhance patient compliance with mammography screening guidelines

David R. Lairson, PhD1, Lillian F. Liao, BA1, William A. Rakowski, PhD2, Jasmin A. Tiro, MPH1, and Sally W. Vernon, PhD1. (1) School of Public Health, University of Texas - Houston, 1200 Herman-Pressler Drive, Houston, TX 77030, 713-500-9176, dlairson@sph.uth.tmc.edu, (2) Dept. of Community Health, Brown University, 97 Waterman Street, Providence, RI

The aim of this study is to document the process, develop a cost model, and estimate the cost of developing a computerized expert system of targeted and tailored letters to improve compliance with mammography screening guidelines for breast cancer screening. The expert system includes five major components, 1) the theoretical framework and supporting literature, 2) variables and questionnaire, 3) motivational messages and algorithms, 4) data base, and 5) testing of the system. The development process is flow-charted and all ingredients are identified, enumerated, and valued by current market prices. The current estimated cost of components 1, 2, and 5 is $69,231. Approximately 68% is attributable to personnel costs, 21% to overhead costs, 11% to travel expenses, and 1% to supply costs. Costs for components 3, 4, and 5 will be added as the system is completed during the next 4 months. Discussion focuses on the degree to which the system may be adapted for other projects and how to allocate cost for this type of investment in health promotion given the perspective of public and private decision-makers.

Learning Objectives: 1. List and describe the steps necessary to develop a computerized targeted and tailored message to promote patient compliance with breast cancer screening guidelines. 2. Identify, enumerate and value the cost elements necessary for developing an expert system to enhance patient compliance with breast cancer screening guidelines

Keywords: Breast Cancer Screening, Cost Issues

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

The 128th Annual Meeting of APHA